Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Revista Espanola De Enfermedades Digestivas|April 4, 2013
Enterocutaneous fistulas and Crohn´s disease: clinical characteristics and response to treatmentS Gómez-Senent, M Barreiro-de-Acosta, V García-SánchezRevista Espanola De Enfermedades Digestivas|November 2, 2007
[Life-threatening acute lower gastrointestinal bleeding in patients with Crohn's disease]M Barreiro de Acosta, S Seijo Ríos, J E Domínguez MuñozMinerva Gastroenterologica E Dietologica|May 31, 2012
Maximizing the effect of biologics in inflammatory bowel diseaseR Souto Rodriguez, J M Swoger, M Barreiro-De Acosta, et al.Revista Espanola De Enfermedades Digestivas|June 8, 2010
NOD2/CARD15: geographic differences in the Spanish population and clinical applications in Crohn's diseaseM Barreiro-de-Acosta, J L Mendoza, R Lana, et al.Journal of Crohn'S & Colitis|November 26, 2011
Emigration to western industrialized countries: A risk factor for developing inflammatory bowel diseaseM Barreiro-de Acosta, A Alvarez Castro, R Souto, et al.Revista Espanola De Enfermedades Digestivas|June 5, 2009
Psychological impact of Crohn's disease on patients in remission: anxiety and depression risksM Iglesias, M Barreiro de Acosta, I Vázquez, et al.Revista Espanola De Enfermedades Digestivas|February 19, 2009
[Secondary amyloidosis in Crohn's disease]S Seijo Ríos, M Barreiro de Acosta, B Vieites Pérez-Quintela, et al.Revista Espanola De Enfermedades Digestivas|December 15, 2010
Health related quality of life in patients with Cohn´s disease in remissionM Iglesias, I Vázquez, M Barreiro-de Acosta, et al.Revista Espanola De Enfermedades Digestivas|November 3, 2010
NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary reportM Barreiro-de Acosta, S Ouburg, S A Morré, et al.Revista De Gastroenterologia De Mexico (English)|December 6, 2021
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCUJ K Yamamoto-Furusho, D Andrade, J Barahona, et al.Pageof 3